Pharmaceutical Nootropics Bromantane Powder Bromantane

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: CQM Bromantane
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Bromantane
• Name: Bromantane Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• CAS No.: 87913-26-6
• Mf: C16h20brn
• MW: 306.24
• Melting Point: 106-108
• Boiling Point: 404.8
• Assay: HPLC 99%
• Application: Nootropics
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• Transport Package: Negotiable
• Specification: 99%
• Trademark: CQM
• Origin: Shaanxi Xi'an
• Production Capacity: 800kg/Month

Product Description

Pharmaceutical Nootropics Bromantane Powder Bromantane

Product Description

Product Details

Product Name	Bromantane
CAS No.	87913-26-6
MF	C16h20brn
MW	306.24
Appearance	White Powder

Bromantane (CAS 54878-11-0), chemically known as *(1R,2S)-3-(4-bromophenyl)-N-[(1,1-dimethylethyl)amino]-2-methyl-2-propanamine*, is a unique psychostimulant and adaptogen with a molecular weight of 270.18 g/mol. This white crystalline powder exhibits dual dopaminergic and glutamatergic activity, originally developed in Russia as Ladasten® for asthenic conditions. With ≥98% HPLC purity, it demonstrates excellent solubility in ethanol (>50 mg/mL) and stability at room temperature (15-25°C) when protected from light. Its pharmacokinetic profile includes rapid absorption (T_max: 1.5–2 hours) and a half-life of 6–8 hours, metabolized primarily via CYP2D6. Bromantane's non-addictive nature and lack of significant toxicity (LD₅₀ >1000 mg/kg in rats) make it a promising research compound for neuroenhancement and stress resilience studies.

Application&Function

Mechanisms of Action:
1.Dopamine Synthesis Upregulation: Increases tyrosine hydroxylase activity in the striatum (30–50% elevation in animal models);
2.Glutamate Modulation: Enhances AMPA receptor trafficking without excitotoxicity;
3.Adaptogenic Effects: Normalizes HPA axis function under stress;
Clinical & Research Applications:
1.Asthenia Treatment: Approved in Russia for fatigue (50–100 mg/day, 2-week courses);
2.Cognitive Enhancement: Improves working memory in healthy volunteers (p<0.01 vs placebo);
3.Neuroprotection: Reduces oxidative stress markers (MDA ↓40% in preclinical studies);
4.Parkinson's Models: Preserves dopaminergic neurons (MPTP-induced toxicity).

Specification

Certificate of Analysis